The prevalence of non-invasive ventilation and long-term oxygen treatment in Helsinki University Hospital area, Finland

Table 1 Prevalence of NIV and long-term oxygen treatment in Helsinki University Hospital Area on 1.1.2018

Prevalence per 100,000*	All patients	COPD	NMD	RCWD	OHS	ILD	Misc**
NIV (N = 362)	26.7	3.4	6.0	2.4	13.3	0.1	1.6
LTOT (N = 335)	24.6	12.4	0.1	0.4	0.2	5.1	6.3
NIV + LTOT (N = 118)	8.7	4.1	0.1	1.1	2.5	0.1	0.7
All NIV and/or LTOT treatments (N = 815)	60.0	20.0	6.3	4.0	16.0	5.3	8.5

COPD, chronic obstructive pulmonary disease; NMD, neuromuscular disease; RCWD, restrictive chest wall disease; OHS, obesity-hypoventilation syndrome; ILD, interstitial lung disease; Misc, miscellaneous; NIV, non-invasive ventilation; LTOT, long-term oxygen treatment
*Children under 16, patients with invasive mechanical ventilation or sleep apnea are excluded from the study
**Misc group includes heart disease and cancer patients

ISSN: 1471-2466